Vanguard Group
NKTR icon

Vanguard Group’s Nektar Therapeutics NKTR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$18.9M Sell
729,492
-11,580,196
-94% -$299M ﹤0.01% 2585
2025
Q1
$8.37M Sell
12,309,688
-18,334
-0.1% -$12.5K ﹤0.01% 2944
2024
Q4
$11.5M Sell
12,328,022
-792,771
-6% -$737K ﹤0.01% 2880
2024
Q3
$17.1M Buy
13,120,793
+153,295
+1% +$199K ﹤0.01% 2666
2024
Q2
$16.1M Buy
12,967,498
+918,360
+8% +$1.14M ﹤0.01% 2670
2024
Q1
$11.3M Buy
12,049,138
+6,265
+0.1% +$5.85K ﹤0.01% 2893
2023
Q4
$6.8M Sell
12,042,873
-18,274
-0.2% -$10.3K ﹤0.01% 3155
2023
Q3
$7.18M Buy
12,061,147
+4,960
+0% +$2.95K ﹤0.01% 3083
2023
Q2
$6.93M Sell
12,056,187
-7,652,250
-39% -$4.4M ﹤0.01% 3147
2023
Q1
$13.9M Sell
19,708,437
-3,357,338
-15% -$2.36M ﹤0.01% 2765
2022
Q4
$52.1M Sell
23,065,775
-99,169
-0.4% -$224K ﹤0.01% 2168
2022
Q3
$74.1M Buy
23,164,944
+2,559,732
+12% +$8.19M ﹤0.01% 1974
2022
Q2
$78.3M Buy
20,605,212
+1,174,827
+6% +$4.46M ﹤0.01% 1962
2022
Q1
$105M Buy
19,430,385
+918,474
+5% +$4.95M ﹤0.01% 1911
2021
Q4
$250M Buy
18,511,911
+1,403,646
+8% +$19M 0.01% 1470
2021
Q3
$307M Buy
17,108,265
+102,719
+0.6% +$1.84M 0.01% 1312
2021
Q2
$292M Buy
17,005,546
+291,715
+2% +$5.01M 0.01% 1371
2021
Q1
$334M Buy
16,713,831
+441,246
+3% +$8.82M 0.01% 1236
2020
Q4
$277M Buy
16,272,585
+438,808
+3% +$7.46M 0.01% 1260
2020
Q3
$263M Sell
15,833,777
-667,085
-4% -$11.1M 0.01% 1095
2020
Q2
$382M Sell
16,500,862
-20,322
-0.1% -$471K 0.01% 888
2020
Q1
$295M Buy
16,521,184
+363,573
+2% +$6.49M 0.01% 900
2019
Q4
$349M Sell
16,157,611
-1,670,694
-9% -$36.1M 0.01% 1027
2019
Q3
$325M Sell
17,828,305
-684,467
-4% -$12.5M 0.01% 1027
2019
Q2
$659M Buy
18,512,772
+356,193
+2% +$12.7M 0.02% 680
2019
Q1
$610M Sell
18,156,579
-147,952
-0.8% -$4.97M 0.02% 700
2018
Q4
$602M Sell
18,304,531
-618,119
-3% -$20.3M 0.03% 626
2018
Q3
$1.15B Buy
18,922,650
+660,907
+4% +$40.3M 0.05% 459
2018
Q2
$892M Buy
18,261,743
+1,032,422
+6% +$50.4M 0.04% 545
2018
Q1
$1.83B Buy
17,229,321
+2,417,014
+16% +$257M 0.08% 262
2017
Q4
$885M Buy
14,812,307
+508,827
+4% +$30.4M 0.04% 534
2017
Q3
$343M Buy
14,303,480
+293,586
+2% +$7.05M 0.02% 926
2017
Q2
$274M Buy
14,009,894
+401,914
+3% +$7.86M 0.01% 1023
2017
Q1
$319M Buy
13,607,980
+634,700
+5% +$14.9M 0.02% 915
2016
Q4
$159M Buy
12,973,280
+1,383,706
+12% +$17M 0.01% 1325
2016
Q3
$199M Sell
11,589,574
-60,894
-0.5% -$1.05M 0.01% 1112
2016
Q2
$166M Buy
11,650,468
+301,245
+3% +$4.29M 0.01% 1173
2016
Q1
$156M Buy
11,349,223
+883,334
+8% +$12.1M 0.01% 1174
2015
Q4
$176M Buy
10,465,889
+259,512
+3% +$4.37M 0.01% 1091
2015
Q3
$112M Buy
10,206,377
+264,104
+3% +$2.89M 0.01% 1354
2015
Q2
$124M Buy
9,942,273
+1,200,024
+14% +$15M 0.01% 1374
2015
Q1
$96.2M Buy
8,742,249
+437,800
+5% +$4.82M 0.01% 1530
2014
Q4
$129M Buy
8,304,449
+184,525
+2% +$2.86M 0.01% 1244
2014
Q3
$98M Buy
8,119,924
+39,684
+0.5% +$479K 0.01% 1366
2014
Q2
$104M Sell
8,080,240
-66,831
-0.8% -$857K 0.01% 1370
2014
Q1
$98.7M Buy
8,147,071
+619,633
+8% +$7.51M 0.01% 1352
2013
Q4
$85.4M Buy
7,527,438
+484,069
+7% +$5.49M 0.01% 1420
2013
Q3
$73.6M Buy
7,043,369
+219,336
+3% +$2.29M 0.01% 1450
2013
Q2
$78.8M Buy
+6,824,033
New +$78.8M 0.01% 1325